No Data
No Data
No Data
No Data
No Data
OBiO Technology Will Showcase at American Society of Gene & Cell Therapy
OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene...
PR NewswireApr 28 12:00 ET
Heyuan Biotech (688238.SH) announced its 2023 annual results, with a net loss of 128 million yuan, changing from profit to loss over the previous year
Heyuan Biotech (688238.SH) disclosed its 2023 annual report, and the company achieved revenue of 2 in 2023...
Zhitong FinanceApr 24 09:50 ET
Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Unfortunately for some shareholders, the Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) share price has dived 26% in the last thirty days, prolonging recent pain. For any long-term shareholde
Simply Wall StApr 15 18:26 ET
Is Obio Technology (Shanghai) (SHSE:688238) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
Simply Wall StMar 15 18:03 ET
5.2 million restricted shares of Heyuan Biotech (688238.SH) will be listed and circulated on March 22
Heyuan Biotech (688238.SH) announced that the total number of shares in circulation in the company's current stock listing is 5.2 million shares, which are listed and in circulation...
Zhitong FinanceMar 13 06:20 ET
Heyuan Biotech (688238.SH) Performance Report: Net loss of 128 million yuan in 2023
On February 23, Gelonghui (688238.SH) announced its 2023 annual performance report. During the reporting period, the company achieved operating income of 213.0462 million yuan, a decrease of 26.86% over the same period of the previous year; realized net profit attributable to owners of the parent company - 12,8013,500 yuan, a decrease of 16.727 million yuan over the same period of the previous year; realized net profit attributable to owners of the parent company after deduction of non-recurring profit and loss - 13.32417 million yuan, a decrease of 164.2681 million yuan from the same period last year.
Gelonghui FinanceFeb 23 05:52 ET
No Data
No Data